Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126549811 | 12654981 | 1 | I | 20160729 | 20160802 | 20160816 | 20160816 | EXP | US-GLAXOSMITHKLINE-US2016GSK112755 | GLAXOSMITHKLINE | 60.76 | YR | F | Y | 0.00000 | 20160816 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126549811 | 12654981 | 1 | PS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | U | 5ZP1002 | 21077 | INHALATION POWDER | ||||||||
126549811 | 12654981 | 2 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | UNK | U | 6ZP5925 | 0 | |||||||||
126549811 | 12654981 | 3 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126549811 | 12654981 | 1 | Chronic obstructive pulmonary disease |
126549811 | 12654981 | 2 | Asthma |
126549811 | 12654981 | 3 | Chronic obstructive pulmonary disease |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126549811 | 12654981 | Bronchitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126549811 | 12654981 | 1 | 2006 | 0 | ||
126549811 | 12654981 | 2 | 1997 | 0 |